News

While these statistics are concerning, Associate Professor Sally Stephenson is leading a QUT research team to improve these outcomes. 

Thanks to the generous support of donors, the team is able to progress their research.  

Two master’s students, Mr Zeng Yap and Dilsher Gill, are developing targeted therapies that actively seek out cancer proteins and kill harmful cells.  

Their research has found that many proteins in cancer cells are modified after they are made. Work continues in this space to understand how we can stop these modifications. 

Zeng’s research looks at different changes that occur in a protein. These changes to proteins are essential in cancer cell proliferation. His research has successfully identified the part of the protein that inhibitor molecules should target. 

Dilsher’s research explores a new protein modification and seeks to identify impacted proteins in prostate cancers. 

Within the research team’s main project, donor supported funding has been used to extend screening of large numbers of molecules that can inhibit the modification reaction. This has contributed to identifying molecules for the first novel protein target that it is hoped will lead to the development of precision treatments for prostate cancer.  

These research outcomes bring us closer to developing targeted treatments for prostate cancer, which will help improve patient outcomes. 

Thank you for your support. Together, we can continue to improve prostate cancer outcomes.